Fortress Biotech and Afya to Report Q2 2026 Earnings

Fortress Biotech (NASDAQ:FBIO) is slated to release its Q2 2026 results before the market opens on Thursday, August 13. Analysts project a loss of $0.20 per share on revenue of $18.30 million. The stock opened at $2.79, with a market cap of $92.68 million. Recent institutional activity includes new positions by Quadrature Capital, Man Group, Bridgeway Capital, Panagora Asset Management and a stake increase by State Street Corp.

Afya (NASDAQ:AFYA) is expected to issue its Q2 2026 earnings before the market opens on Wednesday, August 12. Forecasts call for earnings of $0.4054 per share and revenue of $190.51 million. The shares opened at $13.94, giving the company a market cap of $1.31 billion. Insider transactions were reported, with VP Gomiero Mirella Basolli and VP Lelio De Souza Junior selling significant share blocks. State Street Corp also boosted its holding in Afya during the fourth quarter.